Skip to main content
Book cover

RNA Activation

  • Book
  • © 2017

Overview

  • Provides a comprehensive knowledge of RNA activation
  • Chapters highlight recent advances in specific topics
  • Refers to several kinds of cancer
  • Contributed by world recognized experts in this field

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 983)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Exogenous RNAa

  2. Endogenous RNAa

  3. RNA Activation Guided by Other Small RNAs

  4. Developing RNAa-Based Therapeutics

Keywords

About this book

This book offers an essential guide to RNA activation (RNAa), an emerging and fascinating new field. RNAa is a small RNA-guided and Argonaute-dependent gene regulation phenomenon in which promoter-targeted short double-stranded RNAs (dsRNAs) induce target gene expression at the transcriptional level. It occurs primarily in the nucleus and can be mediated by artificially designed short duplex RNAs that target regulatory sequences (e.g., promoters, genes’ 3’ termini and enhancers) and naturally occurring small RNAs (e.g., miRNAs and C. elegans 22G-RNAs).

With contributions from internationally respected RNA experts, this book provides comprehensive coverage of different RNAa mechanisms and a timely update on recent advances in RNAa research, with a focus on developing RNAa-based therapeutics. Special chapters are also devoted to the topics of gene activation induced by antisense oligonucleotides and the CRISPR system. As the first book to cover RNAa, it will be of interest to a wide audience, from scientists in academia and the pharmaceutical industry to clinicians who wish to further explore the biology of RNAa and related phenomena, so as to harness their full potential for use in biotechnology and drug development.

Editors and Affiliations

  • Laboratory of Molecular Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

    Long-Cheng Li

About the editor

Dr. Long-Cheng Li is a professor at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

Bibliographic Information

Publish with us